-
Global Trends
Novel Monoclonal Antibody Gains FDA Clearance for Generalized Myasthenia Gravis
The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Amgen’s monoclonal antibody, Uplizna (inebilizumab). The new…
Read More » -
Global Trends
Regulator Authorizes New Oral Antibiotic Option for Gonorrhea
The U.S. Food and Drug Administration (FDA) has announced a decision to expand the usage approval for GSK’s antibiotic, Blujepa,…
Read More » -
Local Dynamics
Healthcare News: Vietnam – US Collaboration on Anti-Infection Technology
On the afternoon of December 8 in Hanoi, Deputy Minister of Health Đỗ Xuân Tuyên hosted a working session with…
Read More » -
Local Dynamics
Medical News: Advancing Regenerative Medicine in Vietnam-Japan Partnership
On the morning of December 6, 2025, at Thang Long Lạc Việt International Hospital, the Lạc Việt Friendship Hospital System…
Read More » -
Local Dynamics
Medical News: Provincial Level Microsurgery Breakthrough
Thái Bình General Hospital (Hưng Yên) has marked a significant milestone in high-tech development by successfully mastering the complex technique…
Read More » -
Local Dynamics
Preventive Health News: Comprehensive Vaccination Communication Program Launched
On the afternoon of December 11, the Department of Preventive Medicine (Ministry of Health) collaborated with Sanofi – Aventis Vietnam…
Read More » -
Local Dynamics
Health Tech News: Telemedicine Becomes a Strategic Component
On December 11 in Hanoi, the Agency of Health Examination and Treatment Administration (Ministry of Health) coordinated with UNDP, KOFIH,…
Read More » -
Local Dynamics
Administrative News: Thanh Hóa Appoints New Leadership for Department of Health
On the morning of December 12, the Thanh Hóa Provincial Department of Health held a conference to announce the Provincial…
Read More » -
Local Dynamics
Scientific Bulletin: New Approach in Heart Failure Treatment
The 2nd National Scientific Conference on Heart Failure, held in Ho Chi Minh City on December 13, focused on the…
Read More » -
Global Trends
Pharmaceutical Corporation Breaks Ground on Flagship US Production Center in North Carolina
EAST HANOVER, December 12, 2025 – The global pharmaceutical corporation Novartis has commenced construction on its major strategic manufacturing center…
Read More » -
Global Trends
Zydus Lifesciences and Formycon Partner to Supply Keytruda® Biosimilar for Cancer Patients in US and Canada
Zydus Lifesciences (India) and Formycon AG (Germany) have entered into an exclusive strategic partnership to license and supply FYB206, a…
Read More » -
Global Trends
Novartis and UK Biotech Relation Announce R&D Collaboration
Novartis, the major pharmaceutical corporation, has signed a multi-program research and development partnership agreement with Relation Therapeutics, an AI-driven biotech…
Read More » -
Global Trends
Moderna Partners with Nanexa to Extend Injectable Drug Efficacy
Moderna, the mRNA specialist, has entered a licensing agreement with Nanexa, a Swedish biotech company, to incorporate tailored release profiles…
Read More » -
Global Trends
Pfizer Continues Global Restructuring, Hundreds of Swiss Employees Affected by Layoffs
Pharmaceutical giant Pfizer is expanding its global cost-cutting agenda, with reports indicating that hundreds of employees in Switzerland are set…
Read More » -
Global Trends
Geron Pharmaceutical Corporation Implements Second Round of Workforce Reduction
Geron Corporation, the pharmaceutical company based in Foster City, California, has disclosed a substantial restructuring plan that will involve laying…
Read More » -
Local Dynamics
State-of-the-Art Medical Facility Set to Launch in Ninh Binh
The second facility of the Vietnam – Germany Friendship Hospital, located in Ninh Binh, is preparing to commence operations starting…
Read More » -
Global Trends
Pharmaceutical Firm Introduces Dual-Action Therapy for Metabolic Conditions
Cipla Limited has unveiled a new medication, known as Yurpeak, which contains the active pharmaceutical ingredient tirzepatide. This injectable treatment…
Read More » -
Global Trends
European Pharma Giants Sanofi and GSK Enter Preclinical Collaboration Deals
Rival European pharmaceutical companies Sanofi and GSK have both forged new partnership agreements aimed at strengthening their respective preclinical research…
Read More » -
Global Trends
Novartis Reports Positive Phase III Trial Data for Ianalumab in Immune Thrombocytopenia
Novartis has announced favorable outcomes from the Phase III clinical trial VAYHIT2, which assessed the efficacy of ianalumab combined with…
Read More » -
Global Trends
Paradigm Health Acquires Flatiron Clinical Research Arm, Raises $78M to Broaden Trial Access
Paradigm Health has completed the acquisition of Flatiron Health’s clinical research business shortly after successfully raising $78 million in a…
Read More »
